Recombinant Human B7-H3 Fc Chimera Avi-tag Protein, CF Summary
Accession # NP_079516.1
Complete Your Research
Complete Your Experiment
CF stands for Carrier Free (CF). We typically add Bovine Serum Albumin (BSA) as a carrier protein to our recombinant proteins. Adding a carrier protein enhances protein stability, increases shelf-life, and allows the recombinant protein to be stored at a more dilute concentration. The carrier free version does not contain BSA.
In general, we advise purchasing the recombinant protein with BSA for use in cell or tissue culture, or as an ELISA standard. In contrast, the carrier free protein is recommended for applications, in which the presence of BSA could interfere.
|Formulation||Lyophilized from a 0.2 μm filtered solution in PBS with Trehalose.|
|Reconstitution||Reconstitute at 500 μg/mL in PBS.|
|Shipping||The product is shipped at ambient temperature. Upon receipt, store it immediately at the temperature recommended below.|
|Stability & Storage:||Use a manual defrost freezer and avoid repeated freeze-thaw cycles.
When Human B7-H3 Antibody (AF1027) is immobilized at 1 μg/mL, 100 μL/well, the concentration of Biotinylated Recombinant Human B7-H3 Fc Chimera Avi-tag (Catalog # AVI1027) that produces 50% of the optimal binding response is approximately 3-18 ng/mL.
2 μg/lane of Biotinylated Recombinant Human B7-H3 Fc Chimera Avi-tag Protein (Catalog # AVI1027) was resolved with SDS-PAGE under reducing (R) and non-reducing (NR) conditions and visualized by Coomassie® Blue staining, showing bands at 62-74 kDa and 120-150 kDa, respectively.
T cells require a signal induced by the engagement of the T cell receptor and a "co-stimulatory" signal(s) through distinct T cell surface molecules for optimal T cell expansion and activation. Members of the B7 superfamily of counter-receptors were identified by their ability to interact with co-stimulatory molecules found on the surface of T cells. Members of the B7 superfamily include B7-1 (CD80), B7-2 (CD86), B7-H1 (PD-L1), B7-H2 (B7RP-1), PD-L2 (B7-DC), and B7-H3 (1). Human B7-H3 was originally identified as a 316 amino acid (aa) type I membrane precursor protein with a putative 28 aa signal peptide, a 217 aa extracellular region containing one V-like and one C-like Ig domain, a transmembrane region, and a 45 aa cytoplasmic domain (2). Subsequently, a second dominantly expressed form of human B7-H3, containing a splice variation that duplicates the V-like and C-like Ig domains, was found. The 534 aa splice variant of B7-H3 has been referred to as B7-H3b, 4Ig‑B7‑H3, and B7‑H3VCVC (3). RT-PCR transcripts for both B7-H3 and 4Ig‑B7‑H3 have been found in all tissues except peripheral blood leukocytes (5). Southern blot analysis indicates that the 4Ig-B7-H3 isoform of B7‑H3 is the predominate isoform expressed in human tissues (5). In mouse, only a single form of B7-H3 containing one V-like and one C-like Ig domain was detected (5). Mouse and human B7-H3 share 87% aa sequence identity (3). B7-H3 has been shown to be expressed at very high levels in immature dendritic cells, at moderate levels on mature dendritic cells, LPS stimulated immature dendritic cells and LPS stimulated monocytes, and at low levels on resting monocytes (3). B7-H3 binds to activated T cells via an as yet unidentified receptor. In assays using sub-optimal amount so anti-CD3 stimulation, 2Ig‑B7‑H3 enhances T cell proliferation, T cell interferon-gamma (IFN‑gamma ) production, and cytotoxic T cells induction (2). In an assay in which cells were transfected with 4Ig-B7-H3 or 2Ig‑B7‑H3 and anti-CD3 antibody was added, neither 4Ig-B7-H3 nor 2Ig‑B7‑H3 was capable of co‑stimulating T cell proliferation or IFN-gamma production (4, 5). Our Avi-tag Biotinylated human B7-H3 features biotinylation at a single site contained within the Avi-tag, a unique 15 amino acid peptide. Protein orientation will be uniform when bound to streptavidin-coated surface due to the precise control of biotinylation and the rest of the protein is unchanged so there is no interference in the protein's bioactivity.
- Coyle, A.J. and J.-C. Gutierrez-Ramos (2001) Nature Immunol. 2:203.
- Chapoval, A.I. et al. (2001) Nature Immunol. 2:269.
- Sun, M. et al. (2002) J. Immunol. 168:6294.
- Steinberger, et al. (2004) J. Immunol. 172:2352.
- Ling, V. et al. (2003) Genomic 82:365.
No product specific FAQs exist for this product, however you mayView all Proteins and Enzyme FAQs
Supplemental Cell Selection Products
Supplemental ELISA Products
Reviews for Recombinant Human B7-H3 Fc Chimera Avi-tag Protein, CF
There are currently no reviews for this product. Be the first to review Recombinant Human B7-H3 Fc Chimera Avi-tag Protein, CF and earn rewards!
Have you used Recombinant Human B7-H3 Fc Chimera Avi-tag Protein, CF?
Submit a review and receive an Amazon gift card.
$25/€18/£15/$25CAN/¥75 Yuan/¥1250 Yen for a review with an image
$10/€7/£6/$10 CAD/¥70 Yuan/¥1110 Yen for a review without an image